News 06.12.2023 Philochem launches clinical trial for tumor imaging Philochem and Blue Earth Diagnostics have examined their first three patients as part of a Phase 1 clinical trial. The trial aims to develop a sm...
News 11.12.2023 Five startups advance to final phase of DayOne Health 4.0 Five international healthcare startups – including the Bern-based startup machineMD – have made it to the final phase of DayOne Health 4.0. With ...
Evento di terzi Bridging Innovation: Unire i Tech Leader di Bergamo e Greater Zurich Area Bergamo Italy
News 12.07.2023 EBAMed raises EUR 14.35 million to propel its groundbreaking cardiac radiation ablation therapy Geneva-based medtech EBAMed has successfully secured EUR 14.35 million in Series A funding. This financing will accelerate the development of the...
Spotlight 15.06.2023 Access to Ecosystem Switzerland is a global leader in biotech, medtech and pharma. Find out what makes the Swiss life science industry unique and how your life scien...
Global Opportunities 27.06.2022 Mailand verwandelt ehemaliges Expo-Gelände in grosses Innovationsviertel Nur etwa 40 km von der Schweizer Grenze entfernt, bietet das neue Innovationsviertel ein einzigartiges Umfeld für Schweizer Unternehmen, die bere...
Global Opportunities 20.07.2022 Milan reconvertit le site d’Expo 2015 en pôle d'innovation À quelque 40 km de la frontière suisse, le nouveau pôle offre un écosystème unique aux entreprises suisses qui sont déjà actives en Italie ou qui...
Global Opportunities 20.06.2022 Milano transforms Expo area in major Innovation District Just some 40km from the Swiss border, the new pole offers a unique ecosystem for Swiss companies who are already active in Italy or monitoring up...
News 17.11.2021 Inflamalps takes part in a significant biopharmaceutical research project Biopharmaceutical company Inflamalps has just entered a major Innosuisse project, which aims to discover at least one new class of antimicrobial ...
News 27.01.2021 Basel researchers developing universal cancer therapy Researchers from Basel are working on the development of a therapy in which pre-prepared immune cells can be used to treat any form of cancer imm...